Electropharmacology of Diltiazem in a Chronic Canine Myocardial Infarction, Ventricular Tachyarrhythmia Model

  • Masahito Naito
  • Makoto Miyairi
  • Tetsuyoshi Asato
  • Hideki Nagoshi
  • Masasada Honda
  • Eric L. Michelson
  • Leonard S. Dreifus
Conference paper

Summary

The electropharmacology of diltiazem was evaluated in 11 dogs with chronic myocardial infarction susceptible to the initiation of sustained ventricular tachyarrhythmias (VTs) using programmed pacing. Dogs were studied open chest under pentobarbital anesthesia both before and after either 0.2 (N = 5), 0.4 (N = 5) or 0.8 mg/kg (N = 5) intravenous diltiazem infused over 5 mimutes. Two doses were studied in 4 dogs. The maximal changes in heart rate, AH, HV and QTc intervals, QRS duration and sinus node recovery time were determined. Mean transmyocardial conduction times from endocardium to epicardium, and excitability thresholds and ventricular refractory periods in both normal and infarct tissue were also determined. Although diltiazem had significant doserelated effects on the heart rate, AH interval and sinus node recovery time at these dosages, diltiazem had no significant effect on the transmyocardial conduction times, excitability thresholds or ventricular refractory periods of either normal or chronically infarcted myocardium. Correspondingly, di1tiazem also failed to prevent the initiation of either ventricular tachycardia or fibrillation by programmed pacing in any of these 11 dogs.

Keywords

Ischemia Amide Cardiol Lidocaine Verapamil 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Karagueuzian HS, Fnoglio JJ, Weiss MB: Protracted ventricular tachycardia induced by premature stimulation of the canine heart after coronary artery occlusion and reperfusion. Circ Res 1979; 44: 833.CrossRefPubMedGoogle Scholar
  2. 2.
    Michelson EL, Spear JF, Moore EN: Electrophysiologic and anatomic correlates of sustained ventricular tachyarrhythmias in a model of chronic myocardial infarction. Am J Cardiol 1980;45: 583.CrossRefPubMedGoogle Scholar
  3. 3.
    Gibson JK, Lucchesi BR: Electrophysiologic actions of UM-272 (pranolium) on reentrant ventricular arrhythmias in postinfarction canine myocardium. J Pharmacol Exp Ther 1980; 214:347.PubMedGoogle Scholar
  4. 4.
    Garan H, Fallon JT, Ruskin JN: Sustained ventricular tachycardia in recent canine myocardial infarction. Circulation 1978; 57: 845.CrossRefGoogle Scholar
  5. 5.
    Michelson EL, Spear JF, Moore EN: Effects of procaineamide on strength-interval relations in normal and chronically infarcted myocardium. Am J Cardiol 1981; 47: 1223.CrossRefPubMedGoogle Scholar
  6. 6.
    Michelson EL, Naito M, David D: Meobentine sulfate: Antiarrhythmic efficacy and mechanism of action in a chronic canine model of myocardial infarction susceptible to ventricular tachyarrhythmias. Am J Cardiol 1981; 47: 392.CrossRefGoogle Scholar
  7. 7.
    Michelson EL, Spear JF, Moore EN: Description of chronic canine myocardial infarction models suitable for the electropharmacologic evaluation of new antiarrhythmic drugs. In: Morganroth J, Moore EN, Dreifus LS, Michelson EL, eds. The evaluation of new antiarrhythmic drugs. The Hague,The Netherlands: Martinus Nijhoff Publishers, 1980: 33.Google Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt 1983

Authors and Affiliations

  • Masahito Naito
    • 1
  • Makoto Miyairi
  • Tetsuyoshi Asato
  • Hideki Nagoshi
  • Masasada Honda
  • Eric L. Michelson
  • Leonard S. Dreifus
  1. 1.The 2nd Tokyo National HospitalTokyoJapan

Personalised recommendations